T1	Participants 686 816	Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas were randomised to receive KAb 201
T2	Participants 1063 1088	25 patients were enrolled
T3	Participants 1125 1179	9 to the intravenous and 10 to the intra-arterial arms
